WILLIAM L. BROWN, PHARMACIST
Pharmacy at 116 St, Cleveland, OH

4270937, Jun 2, 1981

Apr 18, 1979

6/031318

Robert J. Adler - Shaker Hts. OH
Coleman B. Brosilow - Cleveland Hts. OH
William R. Brown - Brecksville OH
Nelson C. Gardner - Cleveland Hts. OH

CNG Research Company - Cleveland OH

F25J 300

62 17

A process for separating acid gases such as CO. sub. 2, H. sub. 2 S, and SO. sub. 2, other sulfur-containing molecules such as COS, and other relatively high boiling point impurities from lower boiling point components of a gas stream comprises: dehydrating the gas stream and contacting it, at an elevated pressure and at substantially the dew point temperature of carbon dioxide therein, with a liquid carbon dioxide refrigerant-absorbent to absorb such impurities other than CO. sub. 2, and separating the liquid carbon dioxide and absorbed impurities; condensing CO. sub. 2, and separating the liquid carbon dioxide and absorbed impurities; condensing CO. sub. 2 from the residual gas stream at such pressure, preferably by indirect heat exchange; contacting the residual gas stream at such pressure with a second refrigerant-absorbent below the triple point temperature of carbon dioxide, and separating additional carbon dioxide therewith. The second refrigerant-absorbent is preferably a liquid-solid slurry comprising an organic liquid vehicle and carbon dioxide in the solid phase to provide in situ refrigeration by melting of the solid phase. The final, residual gas stream is heat exchanged to recover its refrigeration potential.

4581052, Apr 8, 1986

Jul 2, 1984

6/626925

Robert J. Adler - Shaker Heights OH
Coleman B. Brosilow - Cleveland Heights OH
William R. Brown - Brecksville OH
Nelson C. Gardner - Cleveland Heights OH

CNG Research Company - Cleveland OH

B01D 904, G02B 112

62535

A crystallization process is disclosed for separating a crystallizable material and an excluded material which is at least partially excluded from the solid phase obtained upon freezing a liquid mixture of the materials. The solid phase is formed and melted at spaced locations in a liquid mixture of the materials and, within the liquid mixture, internal solid and liquid flows are maintained in opposite directions to effect separation of the materials. The solid phase is formed by evaporative cooling of the liquid mixture and melted by direct contact with a condensing vapor phase of the materials, each of these operations being performed substantially at the prevailing triple point locus conditions in the respective locations in the liquid mixture.

5681360, Oct 28, 1997

Jan 11, 1995

8/371136

Lawrence A. Siwajek - Bentleyville OH
W. Jeffrey Cook - Cleveland Heights OH
William R. Brown - Brecksville OH

Acrion Technologies, Inc. - Valley View OH

C01B 332

481273

A process for concentrating and recovering methane and carbon dioxide from landfill gas includes absorption of commonly occurring pollutants using a reduced amount of carbon dioxide absorbent which itself may be an in situ derived and recoverable constituent. Separated methane may be concentrated into a high heating value fuel, and a highly pure food-grade carbon dioxide product may also be recovered. Process streams may be used to provide fuel for compression and refrigeration and/or to regenerate carbon dioxide absorbent.

2013029, Nov 7, 2013

Dec 19, 2011

13/996371

Christopher W. Boyce - Flemington NJ, US
Salem Fevrier - Cranford NJ, US
Kevin D. McCormick - Basking Ridge NJ, US
Anandan Palani - Bridgewater NJ, US
Robert G. Aslanian - Rockaway NJ, US
Phieng Siliphaivanh - Newton MA, US
Joey L. Methot - Westwood MA, US
William Colby Brown - Cleveland Heights OH, US
Henry Vaccaro - South Plainfield NJ, US

C07D 215/48, A61K 31/4709, C07D 401/06, C07D 401/12, A61K 45/06, C07D 405/12, C07D 401/14, C07D 491/107, C07D 471/04, A61K 31/4375, A61K 31/47, A61K 31/496

51421018, 546169, 514311, 514314, 546168, 544363, 51425306, 546158, 514312, 546 17, 514278, 546170, 546122, 514300

The invention provides certain quinolines and aza-quinolines of the Formula (I), and their pharmaceutically acceptable salts, wherein E, J, J, J, R, R, R, R, R, R, R, X, Y, b, n, and q are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions associated with uncontrolled or inappropriate stimulation of CRTHfunction.

2013030, Nov 14, 2013

Dec 19, 2011

13/996361

Christopher W. Boyce - Flemington NJ, US
Sylvia Joanna Degrado - Scotch Plains NJ, US
Xiao Chen - Edison NJ, US
Jun Qin - Edison NJ, US
Younong Yu - East Brunswick NJ, US
Kevin D. McCormick - Basking Ridge NJ, US
Anandan Palani - Bridgewater NJ, US
Dong Xiao - Warren NJ, US
Robert George Aslanian - Rockaway NJ, US
Jie Wu - Scotch Plains NJ, US
Ashwin Umesh Rao - Morganville NJ, US
Phieng Siliphaivanh - Newton MA, US
Joey L. Methot - Westwood MA, US
Hongjun Zhang - Newton MA, US
Elizabeth Helen Kelley - Lynnfield MA, US
William Colby Brown - Cleveland Heights OH, US
Qin Jiang - Latham NY, US
Jolicia Polivina Gauuan - Schenectady NY, US
Andrew J. Leyhane - Latham NY, US
Purakkattle Johny Biju - Piscataway NJ, US
Pawan K. Dhondi - Elizabeth NJ, US
Li Dong - Lawrenceville NJ, US
Salem Fevrier - Cranford NJ, US
Xianhai Huang - Warren NJ, US
Henry M. Vaccaro - South Plainfield NJ, US

C07D 241/42, C07D 401/12, C07D 403/06, C07D 471/04, A61K 31/4985, C07D 471/10, C07D 405/12, C07D 401/14, A61K 31/506, A61K 31/55, C07D 417/12, C07D 498/04, C07D 491/107, A61K 45/06, A61K 31/498

51421018, 544353, 514249, 544350, 544230, 51421021, 544295, 540523, 51421207

The invention provides certain quinoxalines and aza-quinoxalines of the Formula (I), and their pharmaceutically acceptable salts, wherein J, J, R, R, R, R, R, R, R, R, X, Y, b, n, and q are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions associated with uncontrolled or inappropriate stimulation of CRTHfunction.